| human | Q5 |
| P6178 | Dimensions author ID | 0622571722.54 |
| P496 | ORCID iD | 0000-0002-9185-6108 |
| P3829 | Publons author ID | 2245684 |
| P1053 | ResearcherID | J-8123-2016 |
| P1153 | Scopus author ID | 50461001700 |
| P108 | employer | The University of Texas MD Anderson Cancer Center | Q1525831 |
| P734 | family name | Arthur | Q14915259 |
| Arthur | Q14915259 | ||
| Arthur | Q14915259 | ||
| P735 | given name | Joseph | Q471788 |
| Joseph | Q471788 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q44337074 | Aberrant Opioid Use and Urine Drug Testing in Outpatient Palliative Care |
| Q50863805 | Assessing patient care in palliative care using the healthcare matrix. |
| Q48307632 | Assessing the prognostic features of a pain classification system in advanced cancer patients |
| Q53057808 | Characteristics of patients with advanced lung cancer referred to a rapid-access supportive care clinic. |
| Q92733399 | Chronic Non-Malignant Pain in Patients with Cancer Seen at a Timely Outpatient Palliative Care Clinic |
| Q92951460 | Concurrent use of opioids with benzodiazepines or nonbenzodiazepine sedatives among patients with cancer referred to an outpatient palliative care clinic |
| Q89421111 | Factors associated with patient-reported subjective well-being among advanced lung or non-colonic gastrointestinal cancer patients |
| Q36522629 | Minimal Clinically Important Difference in the Physical, Emotional, and Total Symptom Distress Scores of the Edmonton Symptom Assessment System |
| Q44349679 | Outcomes of a Specialized Interdisciplinary Approach for Patients with Cancer with Aberrant Opioid-Related Behavior |
| Q35693319 | Patient Perception of Physician Compassion After a More Optimistic vs a Less Optimistic Message: A Randomized Clinical Trial |
| Q38811381 | Perception of Helpfulness of a Question Prompt Sheet Among Cancer Patients Attending Outpatient Palliative Care |
| Q53079719 | Personalized Pain Goal as an Outcome Measure in Routine Cancer Pain Assessment. |
| Q91765789 | Practices and perceptions regarding intravenous opioid infusion and cancer pain management |
| Q37936328 | Quality of the supportive and palliative oncology literature: a focused analysis on randomized controlled trials |
| Q102372791 | Random urine drug testing among patients receiving opioid therapy for cancer pain |
| Q47757581 | Testing the feasibility of using the Edmonton Symptom Assessment System (ESAS) to assess caregiver symptom burden |
| Q52886757 | The impact of a simplified documentation method for the Edmonton classification system for cancer pain (ECS-CP) on clinician utilization. |
| Q51749020 | The minimal clinically important difference of the Richmond Agitation-Sedation Scale in patients with cancer with agitated delirium. |
| Q34458000 | The opioid rotation ratio of hydrocodone to strong opioids in cancer patients |
| Q40449086 | The opioid rotation ratio of strong opioids to transdermal fentanyl in cancer patients. |
| Q85776686 | The routine use of the Edmonton Classification System for Cancer Pain in an outpatient supportive care center |
| Q48431139 | Till death do us part: getting married at the end of life |
| Q89646945 | Urine Drug Testing in Cancer Pain Management |
Search more.